Granite Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-207,799
| Closed | -$14.4M | – | 367 |
|
|
2018
Q3 | $14.4M | Buy |
207,799
+9,025
| +5% | +$626K | 0.83% | 53 |
|
|
2018
Q2 | $15M | Buy |
198,774
+84,567
| +74% | +$6.4M | 0.95% | 33 |
|
|
2018
Q1 | $6.02M | Sell |
114,207
-210
| -0.2% | -$11.1K | 0.4% | 97 |
|
|
2017
Q4 | $6.11M | Buy |
114,417
+3,073
| +3% | +$164K | 0.39% | 99 |
|
|
2017
Q3 | $6.64M | Buy |
111,344
+20,354
| +22% | +$1.21M | 0.41% | 94 |
|
|
2017
Q2 | $7.18M | Buy |
+90,990
| New | +$7.18M | 0.48% | 84 |
|